Haemonetics (HAE) Divestments (2017 - 2024)

Haemonetics has reported Divestments for 5 years, with the latest figure at $1.5 million in Q1 2024.

• On a quarterly basis, Divestments changed N/A year-over-year to $1.5 million in Q1 2024; TTM through Mar 2024 was $1.5 million, a 85.9% decrease from a year earlier, with the FY2025 full-year figure at $43.3 million, up 2786.07% from the prior year.
• Divestments was $1.5 million for Q1 2024 at Haemonetics, down from $10.6 million in the prior quarter.
• The five-year high for Divestments was $45.0 million in Q3 2020, with the low at -$391000.0 in Q4 2020.
• Average Divestments over 3 years is $14.2 million, with a median of $6.1 million recorded in 2022.
• The largest YoY upside for Divestments was 2821.74% in 2022 against a maximum downside of 2821.74% in 2022.
• Over 3 years, Divestments stood at -$391000.0 in 2020, then surged by 2821.74% to $10.6 million in 2022, then sank by 85.9% to $1.5 million in 2024.
• The last three Divestments figures came in at $1.5 million (Q1 2024), $10.6 million (Q1 2022), and -$391000.0 (Q4 2020), per Business Quant data.